PICan: An integromics framework for dynamic cancer biomarker discovery

Modern cancer research on prognostic and predictive biomarkers demands the integration of established and emerging high‐throughput technologies. However, these data are meaningless unless carefully integrated with patient clinical outcome and epidemiological information. Integrated datasets hold the key to discovering new biomarkers and therapeutic targets in cancer. We have developed a novel approach and set of methods for integrating and interrogating phenomic, genomic and clinical data sets to facilitate cancer biomarker discovery and patient stratification. Applied to a known paradigm, the biological and clinical relevance of TP53, PICan was able to recapitulate the known biomarker status and prognostic significance at a DNA, RNA and protein levels.

[1]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[2]  David B. Searls,et al.  Data integration: challenges for drug discovery , 2005, Nature Reviews Drug Discovery.

[3]  M. Salto‐Tellez,et al.  Molecular pathology – The value of an integrative approach , 2014, Molecular oncology.

[4]  P. Hall,et al.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Lewis C Cantley,et al.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy , 2013, Nature Medicine.

[6]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[7]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[8]  E. Rakovitch,et al.  Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ , 2014, Histopathology.

[9]  F. Couch,et al.  Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer , 2014, Journal of the National Cancer Institute.

[10]  Nuria Lopez-Bigas,et al.  Visualizing multidimensional cancer genomics data , 2013, Genome Medicine.

[11]  Enzo Medico,et al.  Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer , 2012, Nature.

[12]  Chao Wang,et al.  Identifying survival associated morphological features of triple negative breast cancer using multiple datasets , 2013, Journal of the American Medical Informatics Association : JAMIA.

[13]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[14]  Chao Wang,et al.  iGPSe: A visual analytic system for integrative genomic based cancer patient stratification , 2014, BMC Bioinformatics.

[15]  A. Frigessi,et al.  Principles and methods of integrative genomic analyses in cancer , 2014, Nature Reviews Cancer.

[16]  Stephen McQuaid,et al.  The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer , 2014, Histopathology.

[17]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Johannes G. Reiter,et al.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.

[19]  P. Hall,et al.  An expression signature for p 53 status in human breast cancer predicts mutation status , transcriptional effects , and patient survival , 2005 .

[20]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[21]  Jeffrey M. Miller,et al.  Harvest: an open platform for developing web-based biomedical data discovery and reporting applications , 2013, J. Am. Medical Informatics Assoc..

[22]  Ignacio González,et al.  integrOmics: an R package to unravel relationships between two omics datasets , 2009, Bioinform..

[23]  Matthew N. McCall,et al.  FROZEN ROBUST MULTI-ARRAY ANALYSIS (fRMA) , 2009 .

[24]  David J. Harrison,et al.  TMA Navigator: network inference, patient stratification and survival analysis with tissue microarray data , 2013, Nucleic Acids Res..